|
Volume 271,
Number 17,
Issue of April 26, 1996 pp. 10121-10129
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Phosphorylation
of Vif and Its Role in HIV-1 Replication
(Received for publication, October 10, 1995; and in revised form, February 21, 1996)
Xiaoyu
Yang
, ,
Joao
Goncalves
, ,
Dana
Gabuzda
Vif is a 23-kDa protein encoded by human immunodeficiency virus,
type 1 (HIV-1) which is important for virion infectivity. Here, we
describe the phosphorylation of HIV-1 Vif and its role in HIV-1
replication. In vivo studies demonstrated that Vif is highly
phosphorylated on serine and threonine residues. To identify
phosphorylation sites and characterize the Vif kinase(s), Vif was
expressed in Escherichia coli and purified for use as a
substrate in in vitro kinase assays. The purified Vif protein
was phosphorylated in vitro on serine and threonine residues
by a kinase(s) present in both cytosol and membrane fractions.
Phosphorylation of Vif was stimulated by phorbol 12-myristate
13-acetate and inhibited by staurosporine and hypericin, a drug with
potent anti-HIV activity. The Vif kinase(s) was resistant to inhibitors
of protein kinase C, cAMP-dependent kinase, and cGMP-dependent kinase,
suggesting that it is distinct from these enzymes. To identify the
phosphorylation sites, P-labeled Vif was digested by V8
protease and the peptides were resolved by reverse-phase high
performance liquid chromatography. Radioactive peptide sequencing
identified three phosphorylation sites within the C terminus,
Ser , Thr , and Thr .
Two-dimensional tryptic phosphopeptide mapping indicated that these
sites are also phosphorylated in vivo. Both Ser and Thr are contained in the recognition motifs
(R/KXXS /T and
R/KXXXS /T ) used by serine/threonine
protein kinases such as cGMP-dependent kinase and PKC. Ser is present in the motif SLQXLA, which is the most highly
conserved sequence among all lentivirus Vif proteins. Mutation of
Ser to alanine resulted in loss of Vif activity and
>90% inhibition of HIV-1 replication. These studies suggest that
phosphorylation of Vif by a serine/threonine protein kinase(s) plays an
important role in regulating HIV-1 replication and infectivity.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. H. Reingewertz, H. Benyamini, M. Lebendiker, D. E. Shalev, and A. Friedler
The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state
Protein Eng. Des. Sel.,
May 1, 2009;
22(5):
281 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Pery, K. S. Rajendran, A. J. Brazier, and D. Gabuzda
Regulation of APOBEC3 Proteins by a Novel YXXL Motif in Human Immunodeficiency Virus Type 1 Vif and Simian Immunodeficiency Virus SIVagm Vif
J. Virol.,
March 1, 2009;
83(5):
2374 - 2381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-S. Chen, W.-H. Huang, S.-Y. Hong, Y.-G. Tsay, and P.-J. Chen
ERK1/2-Mediated Phosphorylation of Small Hepatitis Delta Antigen at Serine 177 Enhances Hepatitis Delta Virus Antigenomic RNA Replication
J. Virol.,
October 1, 2008;
82(19):
9345 - 9358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bernacchi, S. Henriet, P. Dumas, J.-C. Paillart, and R. Marquet
RNA and DNA Binding Properties of HIV-1 Vif Protein: A FLUORESCENCE STUDY
J. Biol. Chem.,
September 7, 2007;
282(36):
26361 - 26368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Henriet, L. Sinck, G. Bec, R. J. Gorelick, R. Marquet, and J.-C. Paillart
Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription
Nucleic Acids Res.,
August 1, 2007;
35(15):
5141 - 5153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-K. Shin, Q. Liu, S. K. Tikoo, L. A. Babiuk, and Y. Zhou
Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation
J. Gen. Virol.,
March 1, 2007;
88(3):
942 - 950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Paul, J. Cui, and E. L. Maynard
Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions
PNAS,
December 5, 2006;
103(49):
18475 - 18480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pace, J. Keller, D. Nolan, I. James, S. Gaudieri, C. Moore, and S. Mallal
Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation.
J. Virol.,
September 1, 2006;
80(18):
9259 - 9269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Santa-Marta, F. A. da Silva, A. M. Fonseca, and J. Goncalves
HIV-1 Vif Can Directly Inhibit Apolipoprotein B mRNA-editing Enzyme Catalytic Polypeptide-like 3G-mediated Cytidine Deamination by Using a Single Amino Acid Interaction and Without Protein Degradation
J. Biol. Chem.,
March 11, 2005;
280(10):
8765 - 8775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Ribeiro, A. Maia e Silva, M. Santa-Marta, A. Pombo, J. Moniz-Pereira, J. Goncalves, and I. Barahona
Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3G
J. Virol.,
January 15, 2005;
79(2):
823 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mehle, J. Goncalves, M. Santa-Marta, M. McPike, and D. Gabuzda
Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation
Genes & Dev.,
December 1, 2004;
18(23):
2861 - 2866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. de Rozieres, C. K. Mathiason, M. R. Rolston, U. Chatterji, E. A. Hoover, and J. H. Elder
Characterization of a Highly Pathogenic Molecular Clone of Feline Immunodeficiency Virus Clade C
J. Virol.,
September 1, 2004;
78(17):
8971 - 8982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Esfandiarei, H. Luo, B. Yanagawa, A. Suarez, D. Dabiri, J. Zhang, and B. M. McManus
Protein Kinase B/Akt Regulates Coxsackievirus B3 Replication through a Mechanism Which Is Not Caspase Dependent
J. Virol.,
April 15, 2004;
78(8):
4289 - 4298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda
Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway
J. Biol. Chem.,
February 27, 2004;
279(9):
7792 - 7798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Baraz, M. Hutoran, I. Blumenzweig, M. Katzenellenbogen, A. Friedler, C. Gilon, M. Steinitz, and M. Kotler
Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region
J. Gen. Virol.,
September 1, 2002;
83(9):
2225 - 2230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Goncalves, F. Silva, A. Freitas-Vieira, M. Santa-Marta, R. Malho, X. Yang, D. Gabuzda, and C. Barbas III
Functional Neutralization of HIV-1 Vif Protein by Intracellular Immunization Inhibits Reverse Transcription and Viral Replication
J. Biol. Chem.,
August 23, 2002;
277(35):
32036 - 32045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Khan, H. Akari, S. Kao, C. Aberham, D. Davis, A. Buckler-White, and K. Strebel
Intravirion Processing of the Human Immunodeficiency Virus Type 1 Vif Protein by the Viral Protease May Be Correlated with Vif Function
J. Virol.,
August 12, 2002;
76(18):
9112 - 9123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Muller, T. Patschinsky, and H.-G. Krausslich
The Late-Domain-Containing Protein p6 Is the Predominant Phosphoprotein of Human Immunodeficiency Virus Type 1 Particles
J. Virol.,
February 1, 2002;
76(3):
1015 - 1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bardy, B. Gay, S. Pebernard, N. Chazal, M. Courcoul, R. Vigne, E. Decroly, and P. Boulanger
Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing
J. Gen. Virol.,
November 1, 2001;
82(11):
2719 - 2733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Chatterji, C. K. Grant, and J. H. Elder
Feline Immunodeficiency Virus Vif Localizes to the Nucleus
J. Virol.,
March 15, 2000;
74(6):
2533 - 2540.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Cartier, P. Sivard, C. Tranchat, D. Decimo, C. Desgranges, and V. Boyer
Identification of Three Major Phosphorylation Sites within HIV-1 Capsid. ROLE OF PHOSPHORYLATION DURING THE EARLY STEPS OF INFECTION
J. Biol. Chem.,
July 2, 1999;
274(27):
19434 - 19440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. M. Simon, A. M. Sheehy, E. A. Carpenter, R. A. M. Fouchier, and M. H. Malim
Mutational Analysis of the Human Immunodeficiency Virus Type 1 Vif Protein
J. Virol.,
April 1, 1999;
73(4):
2675 - 2681.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X. Yang and D. Gabuzda
Mitogen-activated Protein Kinase Phosphorylates and Regulates the HIV-1 Vif Protein
J. Biol. Chem.,
November 6, 1998;
273(45):
29879 - 29887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. R. K. Yedavalli, C. Chappey, E. Matala, and N. Ahmad
Conservation of an Intact vif Gene of Human Immunodeficiency Virus Type 1 during Maternal-Fetal Transmission
J. Virol.,
February 1, 1998;
72(2):
1092 - 1102.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|